首页> 外文期刊>Journal of magnetism and magnetic materials >Changes in Ca~(2+) release in human red blood cells under pulsed magnetic field
【24h】

Changes in Ca~(2+) release in human red blood cells under pulsed magnetic field

机译:脉冲磁场下人红细胞Ca〜(2+)释放的变化

获取原文
获取原文并翻译 | 示例
       

摘要

Since Ca~(2+) is related to a highly versatile intracellular signal to regulate many different cellular processes, the role of Ca~(2+) and its concentration in red blood cells (RBCs) are very important. Accordingly, in this study, we have elucidated the relationship between pulsed magnetic field (PMF) and intracellular Ca~(2+) level to understand how PMF affects oxidative stressed RBCs. In addition, the effect of verapamil on RBCs in Ca~(2+) level, compared to the effect of PMF was investigated because verapamil, as a reducing agent, blocks Ca~(2+) influx into RBCs. Tert-butyl hydroperoxide (tBHP) was used to induce oxidative stress in RBCs with various concentrations of 0.1 to 400 mM. Our PMF stimulator has the maximum intensity of 0.27 T at a transition time of 102 us with pulse intervals of 1 Hz. Our result showed that Ca~(2+) level is remarkably decreased in RBCs treated verapamil, RBCs exposed to PMF after tBHP(0.1 mM) treatment, and RBCs treated tBHP(0.1 mM) after PMF exposure, respectively. This means that PMF not only reduces Ca~(2+) level of inner RBC effectively but also blocks inhibiting Ca~(2+) pump ATPase activity. Also it seems that PMF appears to act similar to reducing agent. For hemolysis change in oxidative stressed RBCs with or without PMF, using western blot and gel analysis, it is observed that hemolysis declines in control RBCs and tBHP(0.1 mM)-treated RBCs exposed to PMF, and in verapamil treated sample. The RBC deformability (RBCD) was also improved after PMF exposure. Therefore, the results of the present study support that PMF gives RBCs positive effect consistently in Ca~(2+) level and plays a role in preventing RBC hemolysis from oxidative stress and improving RBCD. In conclusion, our study suggests a possibility to use PMF as a new modality in improving circulatory regulation in hemodynamic derangements in disease. We need to optimize PMF intensity and stimulated duration for clinical use.
机译:由于Ca〜(2+)与调节多种不同细胞过程的高度通用的细胞内信号有关,因此Ca〜(2+)的作用及其在红细胞(RBC)中的浓度非常重要。因此,在这项研究中,我们阐明了脉冲磁场(PMF)与细胞内Ca〜(2+)水平之间的关系,以了解PMF如何影响氧化应激的RBC。另外,由于维拉帕米作为还原剂阻止Ca〜(2+)流入RBC,因此与PMF相比,研究了维拉帕米对Ca〜(2+)水平的红细胞的作用。叔丁基氢过氧化物(tBHP)用于在浓度为0.1至400 mM的RBC中诱导氧化应激。我们的PMF刺激器在102 us的过渡时间以1 Hz的脉冲间隔具有0.27 T的最大强度。我们的结果表明,分别用维拉帕米治疗的红细胞,经tBHP(0.1 mM)处理后暴露于PMF的RBC和经过PMF暴露的tBHP(0.1 mM)处理过的RBC的Ca〜(2+)水平明显降低。这意味着PMF不仅有效地降低了内部RBC的Ca〜(2+)水平,而且阻断了Ca〜(2+)泵ATPase活性的抑制。同样看来,PMF的作用似乎与还原剂相似。对于使用或不使用PMF的氧化应激RBC的溶血变化,使用蛋白质印迹和凝胶分析,观察到暴露于PMF的对照RBC和经tBHP(0.1 mM)处理的RBC以及维拉帕米处理的样品中的溶血作用降低。 PMF暴露后,RBC的可变形性(RBCD)也得到了改善。因此,本研究结果支持PMF在Ca〜(2+)水平上一致地赋予RBC积极的作用,并在防止RBC溶血受到氧化应激和改善RBCD方面发挥作用。总之,我们的研究表明使用PMF作为改善疾病血液动力学紊乱中循环调节的新方法的可能性。我们需要优化PMF强度和刺激的持续时间以用于临床。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号